PAVmed Inc. (PAVM) Form 8-K — Oct 22, 2026
$PAVMForm 8-KItems 1.01, 3.03, 9.01Filed Oct 22, 2026, 5:28 PM ET0001493152-26-048138Original filing
PAVmed's subsidiary Lucid Diagnostics closed a $15.0 million offering of 15,000 shares of newly designated Series C Convertible Preferred Stock at $1,000 per share to accredited investors, effective October 21, 2026. Alongside the offering, Lucid entered into a registration rights agreement to register the resale of common stock issuable upon conversion of the preferred, and filed a Certificate of Designations in Delaware.
Key figures
- Gross Proceeds
- 15000000
- Offering Price
- 1000
- Shares Offered
- 15000
- Closing Date
- 2026-10-21
- Security Type
- Series C Convertible Preferred Stock, par value $0.001 per share
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.